Laxminarayan G Hegde

Title: Laxminarayan G Hegde: Innovator in Uro-selective Adrenoceptor Blockers

Introduction

Laxminarayan G Hegde is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions. His work focuses on creating innovative solutions that enhance treatment efficacy.

Latest Patents

Laxminarayan G Hegde holds a patent for "1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers." This invention relates to novel 1,4-disubstituted piperazine derivatives of Formula I, along with their pharmaceutically acceptable acid addition salts. These compounds exhibit excellent uro-selective α-adrenoceptor antagonistic activity, surpassing that of previously described compounds. The invention holds promise for treating the symptoms of benign prostatic hyperplasia (BPH). It also includes methods for synthesizing these novel compounds, pharmaceutical compositions containing them, and methods for treating BPH symptoms using these compounds. Laxminarayan G Hegde has 1 patent to his name.

Career Highlights

Laxminarayan G Hegde is associated with Ranbaxy Laboratories, Inc., where he has contributed to various research and development projects. His work has been instrumental in advancing the company's pharmaceutical offerings and enhancing patient care.

Collaborations

He has collaborated with notable colleagues such as Nitya Anand and Sanjay Kumar Jain, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Laxminarayan G Hegde's contributions to the field of pharmaceuticals, particularly in developing uro-selective adrenoceptor blockers, highlight his role as an innovator. His work not only advances medical science but also offers hope for patients suffering from conditions like benign prostatic hyperplasia.